Visualitza HVH - Articles científics per matèria "Pàncrees - Càncer - Tractament"
Ara mostrant els elements 1-12 d 12
-
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
(American Society of Clinical Oncology, 2023-04-10) -
Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer
(BMJ Publishing Group, 2021-03-09)